# Study to Assess the Efficacy and Safety of iNCDSS in Type 2 Diabetes Mellitus Patients

> **NCT04642378** · NA · COMPLETED · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 149 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** iNCDSS based insulin regime
- **DRUG:** routine insulin treatment regime

## Key facts

- **NCT ID:** NCT04642378
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-01
- **Primary completion:** 2022-09-08
- **Final completion:** 2022-09-08
- **Target enrollment:** 149 (ACTUAL)
- **Last updated:** 2024-04-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04642378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04642378, "Study to Assess the Efficacy and Safety of iNCDSS in Type 2 Diabetes Mellitus Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04642378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*